Expired Tender Germany ICB TOT Ref. 611178

Agents acting on the renin-angiotensin system Tender - 611178

Tender notice from Germany, published on 07 Apr 2014.

Executive Summary

The AOK - DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN has issued a Tender notice for the procurement of a Agents acting on the renin-angiotensin system in the Germany. This Tender notice was published on 07 Apr 2014 and is scheduled to close on 25 Jan 2016, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 611178, while the tender notice number is 2014/S 022-034028 and Register on the platform.

Key facts

Summary
Agents acting on the renin-angiotensin system
TOT Ref. No.
611178
Document Ref. No.
2014/S 022-034028
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
07 Apr 2014
Bid deadline
25 Jan 2016
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

For the active ingredient combination of irbesartan and hydrochlorothiazide has AOK - The health insurance company for Lower Saxony for the period until the entry into force of exclusive contracts as a result of a formal award procedure in accordance with the regulations of the 4th Part of the GWB all interested pharmaceutical companies, without selection decision, discount contracts. The Contracts are only concluded in the context of "open-house model" and act as a bridge between the start of generic competition (patent expiry) and the Bezuschlagung of exclusive contracts. The contracts offered are not exclusive; Contracts with all market participants (pharmaceutical companies) are desired by the AOK.
In the open-house model are uniform conditions for all participants. Contractual terms, conditions, and access methods are defined: - individual negotiations are generally not performed. The contract periods exceed twenty-four months of the earliest inception of the contract is the 01.04.2014. All contracts end no later than 31.3.2016, regardless of the date of each contract. A candidate or a contract can be made within the 24-month period for each first of the month. There is a right of termination six weeks to the end of the month. AOK - The health insurance company for Lower Saxony reserves the right to replace already during the contract period, the non-exclusive open-house discount agreements with exclusive discount agreements. With the entry into force tendered, exclusive discount contracts, the open-house contracts are terminated in accordance with contractual arrangements, ie the open house contracts terminate automatically. The experience of the AOK Lower Saxony to enter exclusive discount agreements usually 6 to 8 months after the publication of the corresponding procurement notice in the Supplement to the Official Journal of the European Union. The future contractors in the open-house model are asked to respect this tender notices regularly to inform the Supplement to the Official Journal of the European Union.
Interested pharmaceutical company can request the contract documents and contract conditions mentioned under I.1) contact.
Contracts to the drug combination of irbesartan and hydrochlorothiazide are initially terminated with effect from 01.04.2014. Interested parties who wish to become contracting parties to this date must submit the contract documents to be submitted until 28.2.2014 at the stated in the contract documents address. It depends on the access with the AOK Lower Saxony. Later conclusion of contracts are possible during the twenty-four-month maximum term for each first of the month. Organizationally, a lead time of i.d.R. 35 calendar days from the AOK to the work required, such as the agreement message to the Lauer-Taxe ® to guarantee necessary. The exact deadlines for receipt will be given with the contract documents. In the present publication does not constitute the award of a public contract within the meaning of the award Coordination Directive (2004/18/EC) and the procurement law. To ensure the greatest possible degree of transparency going for the intended contracts, the publication will be made in the Supplement to the Official Journal of the European Union. In the absence of an appropriate release form the contract notice will be used. The resulting conceptual specifications, such as the method called "open method" of using this form and notice of publication platform are only owed. Another meaning, particularly a submission to procurement law, in so far they are not mandatory for legal reasons, is not involved.
Main Activity: Other: Statutory Health
[Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.]

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The bid deadline for Agents acting on the renin-angiotensin system was 25 Jan 2016. Bidding is closed.

This tender has been issued by AOK - DIE GESUNDHEITSKASSE FÜR NIEDERSACHSEN in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33622800 - Agents acting on the renin-angiotensin system.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 611178. The purchaser document reference is 2014/S 022-034028.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.